Do you want to read an article? Please log in or register.
Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
PneumoniaRespiratory Tract Infection
Related content
Pneumonia
Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial
Vaccine.
Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA
doi: 10.1016/j.vaccine.
Respiratory Tract Infection
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
PLoS One.
Domínguez Á, Ciruela P, Hernández S, García-García JJ, Soldevila N, Izquierdo C, Moraga-Llop F, Díaz A, F de Sevilla M, González-Peris S, Campins M, Uriona S, Martínez-Osorio J, Solé-Ribalta A, Codina G, Esteva C, Planes AM, Muñoz-Almagro C, Salleras L
doi: 10.1371/journal.
RECOMMENDED
Respiratory Tract Infection
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age
Vaccine.
Karppinen S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, Waris M, Auranen K, Palmu AA, Peltola V
doi: 10.1016/j.vaccine.2019.04.026.
Pneumonia
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies
PLoS One.
Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, Reinert RR, Schmitt HJ, Trucchi C, Vestraeten T, Ansaldi F
doi: 10.1371/
RECOMMENDED
Respiratory Tract Infection
Effects of 13-valent Pneumococcal Conjugate Vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Clin Microbiol Infect.
van Werkhoven CH, Bolkenbaas M, Huijts SM, Verheij TJM, Bonten MJM
doi: 10.1016/j.cmi.2020.09.011.
Pneumonia
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study
Lancet Respir Med.
Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G; SpIDnet group.
doi: 10.1016/S2213-2600
Pneumonia
Pneumococcal whole-cell and protein-based vaccines: changing the paradigm
Expert Rev Vaccines.
Pichichero ME
doi: 10.1080/
Further Publications
Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era
Pediatr Blood Cancer.
Martin OO, Moquist KL, Hennessy JM, Nelson SC
doi: 10.1002/pbc.26713.
RECOMMENDED
Further Publications
Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Mohr A, Plentz A, Sieroslawski A, Pezenburg F, Pfeifer M, Salzberger B, Hitzenbichler F
doi: 10.1016/j.rmed.2020.106207